Both in Pharmaceuticals
Bolt Biotherapeutics vs Biofrontera
Over the past year BOLT returned +11.8% and BFRI returned −20.9%; their daily moves had a correlation of 0.05.
BOLT +11.8% BFRI −20.9%Growth of $1, one year, split-adjusted
| Metric | BOLT | BFRI |
|---|---|---|
| Price | $6.24 | $0.8701 |
| Market cap | $14.7M | $12.9M |
| Today | −5.31% | −0.32% |
| 1 month | +80.9% | −14.3% |
| 6 months | +23.3% | −21.6% |
| Year to date | +14.1% | +52.6% |
| 1 year | +8.9% | −18.7% |
| Revenue growth (YoY) | −99.7% | +32.9% |
| Gross margin | 100.0% | 79.9% |
| Net margin | −154400.0% | −5.0% |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | 0.3× |
| Net cash | $17.6M | $47.0K |
| Dividend yield | — | — |
| Volatility (60d) | 112.1% | 76.2% |
| Short % of float | 1.1% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).